besity is defined as an excessive accumulation of body fat and has been established as a risk factor for diabetes, hypertension, hyperlipidemia, ischemic heart disease and cerebrovascular disease. 1,2 The incidence of obesity in Japan has been increasing every year and is currently reported to be 28.9% for men and 23.1% for women, 3 which is lower than in Western countries, but the percentage of obesity in Japanese men of all generations has increased 1.5-fold over the past 20 years, probably because of the Westernization of lifestyle, particularly the consumption of high-fat food and lack of exercise. Obesity evaluated by body mass index (BMI) in Japanese women older than 60 years has increased, whereas that in women aged in their 20 s to 50 s has been disproportionately decreasing. 4, 5 Does this mean that obesity in young Japanese females is decreasing? However, a higher BMI is not always consistent with excess body fat mass (BFM), thus an exact evaluation of the body composition of Japanese female adolescents is needed and was the aim of the present study, which was designed to both determine whether young women with a normal BMI have a normal body fat mass and to assess their lipid profiles, lipoprotein metabolism, insulin resistance and adipocytokine levels.
22-30% was defined as normal. 8, 9 CFM is the body fat mass in the trunk (kg) and PFM is the body fat in the 4 extremities (kg). Previous studies have confirmed that a significant positive correlation exists between the CFM measured by DEXA and the visceral fat mass measured by magnetic resonance imaging. 10, 11 Therefore, in this study, CFM was used as an index of visceral fat mass.
Biochemical Analysis
Fasting venous samples were collected between the 3 rd and 5 th days of the menstrual cycle when the level of estrogen is lowest and the levels of total cholesterol (TC), triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), free fatty acids (FFA), cholesterol ester transfer protein (CETP), fasting plasma glucose (FPG) and insulin were determined. Low-density lipoprotein-cholesterol (LDL-C) was calculated by Friedewald's formula. 12 The serum lipids were collectively measured at a clinical laboratory test center accredited by the Lipid Standardization Program of the US Centers for Disease Control and Prevention. The FFA levels were measured using a Labosat NEFA (Shinotest Co, Tokyo, Japan). The level of CETP was determined as previously described. 13 Insulin resistance was assessed using the homeostasis model assessment ratio (HOMA-R) formula; 14 HOMA-R was based on the levels of FPG and fasting plasma insulin: HOMA-R = (FPG Table 2 .
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level × fasting insulin level) / 405. The levels of FPG and fasting plasma insulin were measured by Clinilog (A&T Co, Tokyo, Japan) and automated ELISA (TOSO, Tokyo, Japan), respectively. The levels of leptin and adiponectin were determined in serum separated from blood samples by centrifugation and frozen at -80°C, using a Human Leptin RIA kit (Cosmic Corporation, Tokyo, Japan) and a Human Adiponectin RIA kit (Linco Research, Inc, St Charles, MO, USA), respectively.
Statistical Analysis
The clinical and biochemical data of the subjects are shown as the mean ± SD. Data for parameters that had a non-normal distribution are expressed as the median with interquartile ranges. Differences between the normal body fat composition and the normal BMI-high BFM group were evaluated by Student's t-test. Non-normally distributed parameters (BFM, CFM, PFM, TG, FFA, fasting insulin level, HOMA-R and leptin level) were evaluated by Mann-Whitney's test.
The correlation of BFM or CFM with each metabolic parameter was assessed by the Pearson correlation test, and that with non-normally distributed parameters (TG, fasting insulin level, HOMA-R and leptin level) was evaluated after conversion to natural logarithms. All statistical analyses were 2-tailed and performed with SPSS 10.1 (SPSS Inc, Chicago, IL, USA). P values less than 5% were considered to be statistically significant. Table 1 shows the BMI distribution of the 157 subjects; only 6 subjects had a high BMI. Although most of the subjects (130, 82.8%) had BMI <25, a surprising 20.3% of them showed adiposity (BFM >30%).
Results

Anthropometric Measures
The normal BMI-normal BFM group and the normal BMI-high BFM group were compared for body fat composition and biochemical parameters. The weight, waist circumference and hip circumference were significantly greater in the normal BMI-high BFM group than in the normal BFM group ( Table 2 ). The BMI of the normal BMI-high BFM group was significantly greater than that of the normal BFM group. The CFM of the normal BMIhigh BFM group were significantly higher than those of the normal BFM group ( Table 3) . The LBW was slightly lower in the normal BMI-high BFM group than in the normal BFM group, but did not reach statistical significance.
Biochemical Profiles
In comparison with the normal BFM group, the normal BMI-high BFM group had a significantly higher LDL-C and a lower HDL-C level ( Table 4 ). The levels of TC, TG, FFA, or CETP were comparable between the 2 groups, suggesting that the difference in HDL-C was not related to CEPT. FPG and plasma insulin levels and HOMA-R were also similar between the 2 groups. The level of plasma leptin, but not of plasma adiponectin, was significantly higher in the normal BMI-high BFM group than in the normal BFM group ( Table 4) .
There was a significant negative correlation between BFM, CFM and HDL-C (Figure 1 ) and a significant positive correlation between BFM, CFM and TG (Figure 2) . No significant correlation was found between BFM and insulin resistance (indicated by HOMA-R). Although BFM showed no significant correlation with the plasma adiponectin level, CFM had a significant positive correlation with the plasma adiponectin level (Figure 3) . Both BFM and CFM showed a significant positive correlation with the plasma leptin level. In addition, no significant correlation was observed between CFM and HOMA-R.
Discussion
Major Findings
The present study found that approximately 24% of Japanese female adolescents had an adiposity characterized by a high body fat percentage, and 20% of the subjects with a normal BMI had excess body fat, lower HDL-C level, higher LDL-C and leptin levels than subjects with a normal BMI and normal body fat. The normal BMI-high BFM group tended to have a lower lean body weight, which suggests that their adiposity was possibly associated with less skeletal muscle mass and might relate to "central obesity" with a high CFM and could be considered to be in a state of "visceral fat accumulation".
Relationship Between Adiposity and Lipid Metabolism
In the present study, HDL-C was significantly lower and LDL-C higher in the normal BMI-high BFM than in the normal BFM group. Moreover, BFM and CFM were significantly correlated with HDL-C, TG and LDL-C. These findings suggest that lipid profiles were associated with changes in BFM. Upper-body obesity has been associated with an abnormal lipid metabolism (hypertriglyceridemia). 15 Fujioka et al reported abnormal lipid metabolism (hypercholesterolemia and hypertriglyceridemia) in visceral fat obesity, 16 and Seon et al described an association of abdominal fat accumulation with low HDL-C and high TG levels. 17 The lipid metabolism associated with visceral fat accumulation is characterized by elevated serum TG levels associated with reduced HDL-C levels, and an increase in FFA associated with visceral fat accumulation results in an increase in the substrate for the synthesis of very lowdensity lipoproteins; acyl-CoA synthetase activity and microsomal triglyceride transfer protein mRNA levels have been reported as increased in OLETF rats. 18 A significant negative correlation has also been shown between lipoprotein lipase activity and visceral fat accumulation after intravenous injection of heparin. Visceral fat accumulation causes reduced lipoprotein lipase activity and lipoprotein levels, thus resulting in impaired catabolism of lipoproteins, including TG, such as chylomicrons and very lowdensity lipoproteins, thus leading to hypertriglyceridemia. 19 
Relationship Between Adiposity and Glucose Metabolism
The present study noted no significant difference in glucose tolerance between the subjects with a normal BMIhigh BFM and those with a normal BFM, and no significant correlation of HOMA-R with BFM or CFM.
A number of clinical studies have shown a relationship between diabetes mellitus and obesity or atherosclerotic diseases. 20, 21 Obese Caucasian adolescent males and females without metabolic or endocrine disease have significantly lower insulin resistance than normal weight subjects. 22 Middle-aged, non-diabetic females with a high HOMA-R have a significantly higher BFM than those with a low HOMA-R. 23 Healthy, obese African-American and Caucasian-American adolescents with severe insulin resistance have a higher visceral adiposity than those with mild insulin resistance, despite a similar BMI. 24 The lack of any correlation between glucose tolerance and BFM or CFM in the current subjects might be related to their agea and low extent of fat accumulation. The lack of any difference in the glucose tolerance parameters between the groups supports that explanation.
Relationship Between Adiposity and Adipocytokines
The present study found higher plasma leptin levels in the subjects with a normal BMI-high BFM compared with the normal BFM group. In addition, the leptin levels had a significant positive correlation with BFM and CFM. They were significantly higher in obese young subjects than in the non-obese, and a significant positive correlation existed between the plasma leptin level and BFM. 25 In general, increased leptin levels are considered to result in decreased appetite and food intake, leading to weight loss; however, because simple obesity is associated with decreased leptin sensitivity (ie, increased leptin resistance), such an event does not occur. 26 In the present study, plasma adiponectin levels were within normal ranges and no significant difference was noted between the normal BMI-high BFM and normal BMI-normal BFM groups; however, a weak but significant negative correlation was found between CFM and the plasma adiponectin level, presumably because BFM with a normal BMI was not associated with an excessive accumulation of visceral fat. The plasma adiponectin level has been reported as closely related to body fatness and a key factor in the development of type 2 diabetes, metabolic syndrome and atherosclerosis. [27] [28] [29] [30] However, few studies have investigated plasma adiponectin levels in adolescents. Bacha et al reported that adiponectin levels are significantly lower in obese Caucasian male and female youths than in their normal-weight counterparts. 22 Similarly, Hara et al noted significantly lower plasma adiponectin levels in obese Japanese male college students than in their nonobese counterparts, and reported that the plasma adiponectin level had a significant negative correlation with BFM. 25 In conclusion, approximately 24% of Japanese female adolescents had adiposity characterized by a high body fat percentage, and 20% of the subjects considered normal by BMI had an excess amount of body fat. The women had relatively higher lipid and leptin levels, probably because of body fat accumulation. These findings may provide important information for future epidemiological surveys and studies, which are needed to investigate the prognosis for this subset of the population.
